Pharmaceuticals & Medical Devices

Pharmaceuticals & Medical Devices

Pharmaceuticals and health care devices and supplies are strictly regulated. Gain the benefit of best practices honed by our long-term and versatile experience of the field.

Our services include:

Pricing and reimbursability
Marketing regulations and codes of ethics
Contractual matters
Pharmaceutical importing and permitting matters, authority matters
Matters related to pharmaceutical patents (including patent disputes)
Health care devices and supplies, health technology

Our clients include international and domestic pharmaceutical companies and manufacturers, distributors and developers of heath care devices and supplies.

Latest references

DNB Bank ASA – Lease and development of premises

We advised DNB Bank ASA in its agreement with Fennia Mutual Insurance Company on the development and lease of the premises at Fabianinkatu 8, Helsinki. With the lease agreement, DNB Bank ASA will focus all its Finnish operations at the Fabian 8 office. The other tenants at the renewed premises will be DNB Carnegie Investment Bank AB’s Finnish operations and DNB Auto Finance Oy. In connection with the long-term lease agreement, the parties also agreed on a major renovation project to completely refurbish the premises. The object of lease will be completed in the second half of 2027.

Yellow Film Studios – Merger of Yellow Film Studios and REinvent Studios

We advised Yellow Film Studios, the largest independent film and television production company in the Nordics, in its strategic merger with Danish film industry sales and financing studio REinvent Studios. Together they form Reinvent Yellow, a unified hub for television and film production, sales, financing and innovation, combining over three decades of production experience and a vast catalogue of titles.

International reinsurance companies – Ad hoc arbitration proceedings

We successfully represented a panel of reinsurance companies in an international ad hoc arbitration. The dispute arose out of a reinsurance treaty under the terms of which the reinsurers had reinsured a portfolio of risks underwritten by the cedent. The parties disagreed as to whether the reinsurance provided coverage for a certain loss that had occurred because of the market turmoil caused by the Covid-19 pandemic. The case involved highly complex legal and contractual questions requiring special expertise on reinsurance law and practice. The arbitral tribunal rejected the counterparty’s claims for reinsurance compensation against our clients in full. The amount in dispute was approximately EUR 34 million.

byFounders.vc – DataCrunch’s USD 64 million Series A funding round

We supported byFounders.vc as the Finnish counsel in their investment in DataCrunch Oy in a USD 64 million Series A funding round. DataCrunch provides scalable AI compute solutions from energy-efficient data centers in Iceland and Finland. byFounders.vc is the community-powered early-stage venture fund investing in globally ambitious teams connected to the Nordic and Baltic countries.

Latest insights

2.10.2025 – Environment, Energy & Green Transition Fingrid extends restrictions on new energy storage facility connections in Southern Finland until 2029

Konsta Peussa

Marius af Schultén

Konsta Peussa & Marius af Schultén

12.9.2025 – Capital Markets & Public M&A Surely the preparation of interim reports does not need to be an insider project in the future?

Janne Lauha

Teresa Kauppila

Sakari Sedbom

Janne Lauha, Teresa Kauppila & Sakari Sedbom

9.9.2025 Launching C&S MBA Highlights Programme 9.7.2025 – FDI Regulatory Service Defence sector investments and acquisitions – key facts about the Finnish FDI regulation

Kiti Karvinen

Markus Rahnu

Kiti Karvinen & Markus Rahnu

Search from the site.